stem cell therapy cirrhosis

Liver cancer, specifically hepatocellular carcinoma (HCC), is a deadly disease with a low survival rate. The tumor microenvironment of liver cancer creates a challenging environment for traditional treatments to be effective. However, recent advancements in immunotherapy have shown promise in improving the survival rates of patients with treatment-resistant liver cancer. Let’s delve into the promise of stem cell-derived therapy against treatment-resistant liver cancer.